---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-008937"
form_type: "8-K"
ticker: "ITRMF"
cik: "0001659323"
company_name: "Iterum Therapeutics plc"
filed_at: "2024-01-30T23:59:59+00:00"
generated_at: "2026-06-06T15:03:41.876351+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Iterum Therapeutics shareholders reject proposal to issue up to 5M shares without pre-emptive rights

## Summary
- Proposal required 75% approval; received 3,139,498 For vs 2,724,101 Against and 26,719 Abstentions.
- Failure to grant authority limits board's ability to quickly raise capital by issuing new shares.
- Extraordinary general meeting held on January 30, 2024; vote is final.
- No broker non-votes as matter was considered routine under NYSE rules.

## SEC filing metadata
- accession: 0000950170-24-008937
- form_type: 8-K
- ticker: ITRMF
- cik: 0001659323
- company_name: Iterum Therapeutics plc
- filed_at: 2024-01-30T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1659323/000095017024008937/0000950170-24-008937-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1659323/000095017024008937/itrm-20240130.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-008937
- JSON: https://secwatch.observer/filing/0000950170-24-008937.json
- Plain text: https://secwatch.observer/filing/0000950170-24-008937.txt

## Key facts
- Shareholder Votes
  Iterum Therapeutics plc shareholders rejected Board Authority to Issue Ordinary Shares for Cash without First Offering Ordinary Shares to Existing Shareholders at the 2024-01-30 meeting.
  - Outcome: failed
  - Meeting: 2024-01-30
  source text: The shareholders did not approve the grant to the board of directors of authority under Irish law to allot and issue an additional 5,000,000 shares (including rights to acquire such shares) for cash without first offering those shares to existing shareholders under pre-emptive rights that would otherwise apply to the issuance.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1659323/000095017024008937/0000950170-24-008937-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.